Form 4: AbbVie Director Edward J. Rapp Reports Stock Award and Correction of Previous Filing

Director Edward J. Rapp reports acquisition of restricted stock units and correction of a previously filed form regarding AbbVie shares.

Summary

• Edward J. Rapp, a director of AbbVie Inc., filed a Form 4 on May 13, 2025, reporting changes in beneficial ownership.
• The report indicates that Rapp acquired 1,203 restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program on May 9, 2025.
• These restricted stock units will be paid in shares of AbbVie common stock on a one-to-one basis upon separation from service, death, or a change in control.
• The report also includes a correction, adding 1,899 shares that were inadvertently omitted from a previously filed form.
• Following the reported transactions, Rapp directly owns 34,458 shares of AbbVie common stock.
• Rapp's spouse also holds 10,388 shares in trust, but Rapp disclaims beneficial ownership of these shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating neutral sentiment. It reports transactions and corrections without expressing any positive or negative outlook.

Future Outlook

The restricted stock units will be paid out in AbbVie common stock upon the occurrence of certain events such as separation from service, death, or a change in control.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common for publicly traded companies like AbbVie. It provides transparency to investors regarding the holdings and transactions of key personnel.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• The reported transactions have a minimal impact on the overall market capitalization of AbbVie.

Key Dates

Keywords

Form 4, AbbVie, Director, Edward J. Rapp, Restricted Stock Units, Beneficial Ownership, Correction